The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications, Arthritis Rheum, vol.24, pp.899-904, 1981. ,
Ophthalmic manifestations of giant cell arteritis, Rheumatology (Oxford), vol.57, pp.63-72, 2018. ,
Giant cell arteritis i northwestern Spain : a 25-year epidemiologic study, Medicine (Baltimore), vol.86, pp.61-69, 2007. ,
Giant Cell Arteritis: Visual loss is our major concern, J Rheumatol, vol.43, pp.1458-61, 2016. ,
Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis, Ophthalmology, vol.123, pp.1999-2003, 2016. ,
Ocular manifestations of giant cell arteritis ,
, Am J Ophthalmol, vol.125, pp.509-520, 1998.
Poor prognosis of visual outcome after visual loss from giant cell arteritis, Ophthalmology, vol.112, pp.1098-1103, 2005. ,
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients, Am J Med, vol.111, pp.211-217, 2001. ,
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis, Arthritis Rheum, vol.53, pp.293-297, 2005. ,
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis, Arthritis Rheum, vol.41, pp.26-32, 1998. ,
Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort, J Rheumatol, vol.42, pp.309-315, 2015. ,
Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients, Medicine (Baltimore), vol.79, pp.283-292, 2000. ,
The American college of rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum, vol.33, pp.1122-1128, 1990. ,
Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control study, Clin Rheumatol, vol.37, pp.3405-3410, 2018. ,
Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients, Autoimmun Rev, vol.17, pp.391-398, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02263732
Factors associated with relapse and dependence to glucocorticoids in giant-cell arteritis, J Rheumatol, p.181127, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02153822
Giant cell arteritis-related stroke: a retrospective multicenter case-control study, J Rheumatol, vol.44, pp.297-303, 2017. ,
Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis, Medicine (Baltimore), vol.88, pp.227-235, 2009. ,
The association of vascular risk factors with visual loss in giant cell arteritis, Rheumatology (Oxford), vol.56, pp.524-528, 2017. ,
Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision, Ophthalmology, vol.101, pp.1779-1785, 1994. ,
Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy, Semin Arthritis Rheum, vol.30, pp.249-56, 2001. ,
The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis, Semin Arthritis Rheum, vol.38, pp.116-139, 2008. ,
Management of giant cell arteritis: recommendations of the French study group for large vessel vasculitis (GEFA), Rev Med Interne, vol.37, pp.154-165, 2016. ,
BSR and BHPR guidelines for the management of giant cell arteritis, Rheumatology (Oxford), vol.49, pp.1594-1597, 2010. ,
Visual improvement with corticosteroid therapy in giant cell arteritis, Acta Ophthalmol Scand, vol.80, pp.355-367, 2002. ,
Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy, Ophthalmology, vol.110, pp.1204-1215, 2003. ,
Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study, Medicine (Baltimore), vol.95, p.3210, 2016. ,
A probability score to aid the diagnosis of suspected giant cell arteritis, Clin Exp Rheumatol, 2019. ,
The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?, Rheumatology (Oxford), vol.55, pp.66-70, 2016. ,
Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study, Clin Exp Rheumatol, vol.33, pp.103-106, 2015. ,